Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6-Reference-Cited by-同舟云学术

Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6

Published:2010-07 Issue:3 Volume:400 Page:413-433
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Chrencik Jill E.,Patny Akshay,Leung Iris K.,Korniski Brian,Emmons Thomas L.,Hall Troii,Weinberg Robin A.,Gormley Jennifer A.,Williams Jennifer M.,Day Jacqueline E.,Hirsch Jeffrey L.,Kiefer James R.,Leone Joseph W.,Fischer H. David,Sommers Cynthia D.,Huang Horng-Chih,Jacobsen E.J.,Tenbrink Ruth E.,Tomasselli Alfredo G.,Benson Timothy E.

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference48 articles.

1. tyk2, prototype of a novel class of non-receptor tyrosine kinase genes;Firmbach-Kraft;Oncogene,1990

2. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells;Gurniak;Blood,1996

3. Putative tyrosine kinases expressed in K-562 human leukemia cells;Partanen;Proc. Natl Acad. Sci. USA,1990

4. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase;Wilks;Mol. Cell. Biol.,1991

5. Therapeutic targeting of Janus kinases;Pesu;Immunol. Rev.,2008

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tofacitinib in dermatology: a potential opportunity for topical applicability through novel drug-delivery systems;Nanomedicine;2024-01

2. Structural Analysis of Janus Tyrosine Kinase Variants in Hematological Malignancies: Implications for Drug Development and Opportunities for Novel Therapeutic Strategies;International Journal of Molecular Sciences;2023-09-26

3. JAK Inhibitors;Molecules Engineered Against Oncogenic Proteins and Cancer;2023-09-08

4. Off-target pharmacological activity at various kinases: Potential functional and pathological side effects;Journal of Pharmacological and Toxicological Methods;2023-09

5. In silico discovery of potent and selective Janus kinase 3 (JAK3) inhibitors through 3D-QSAR, covalent docking, ADMET analysis, molecular dynamics simulations, and binding free energy of pyrazolopyrimidine derivatives;Journal of Biomolecular Structure and Dynamics;2023-06-20